title: Drug and surfactant transport in Cyclosporine A and Brij 98 laden p-HEMA hydrogels.
abstract: Surfactants are commonly incorporated into hydrogels to increase solute loading and attenuate the release rates. In this paper we focus on understanding and modeling the mechanisms of both surfactant and drug transport in hydrogels. Specifically, we focus on Brij 98 as the surfactant, Cyclosporine A (CyA) as the hydrophobic drug, and poly-hydroxy ethyl methacrylate (p-HEMA) as the polymer. The models developed here are validated by experiments conducted with gels of different thicknesses and surfactant loadings. Also the model is compared with prior experimental studies in literature. The model predicts that the percentage surfactant as well as drug release scales as 1/(surfactant loading)(0.5), and thus a four fold increase in surfactant loading leads to a two fold reduction in percentage release for both drug and surfactant at a given time. The models for the surfactant and drug release are fitted to the experimental data to obtain values of 1.44 x 10(-14) m(2)/s for CyA diffusivity and 414.4 for the partition coefficient between drug concentration inside the micelle and that in the gel. These models can be very helpful in tuning the drug release rates from hydrogels by controlling the surfactant concentration. The results also show that Brij 98 loaded p-HEMA exhibit an extended release of CyA and so contact lenses made with this material can be used for extended ocular delivery of CyA, which is an immunosuppressant drug commonly used for treatment of various ocular ailments.
authors: Chemical Engineering Department, University of Florida, Gainesville, FL 32611-6005, USA.
authors: Yash
authors: Y
authors: Kapoor
authors: Anuj
authors: A
authors: Chauhan
mesh_terms: D016572:Cyclosporine / Q000008:administration & dosage* / Q000737:chemistry*; D003692:Delayed-Action Preparations; D004337:Drug Carriers / Q000737:chemistry; D006801:Humans; D020100:Hydrogels; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000737:chemistry; D008956:Models, Chemical; D009883:Ophthalmic Solutions; D010938:Plant Oils / Q000008:administration & dosage / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000737:chemistry*; D011102:Polyhydroxyethyl Methacrylate / Q000737:chemistry*; D013501:Surface-Active Agents / Q000737:chemistry
chemical_list: D003692:Delayed-Action Preparations; D004337:Drug Carriers; D020100:Hydrogels; D007166:Immunosuppressive Agents; D009883:Ophthalmic Solutions; D010938:Plant Oils; D013501:Surface-Active Agents; D011102:Polyhydroxyethyl Methacrylate; D011092:Polyethylene Glycols; D016572:Cyclosporine; C033084:polyethylene glycol oleyl ether